申请人:Sumitomo Pharma Co., Ltd.
公开号:EP4104861A1
公开(公告)日:2022-12-21
The present invention is to provide a medicament for treating and/or preventing tauopathy by activating the voltage-gated sodium channel (Nav). The present invention relates to a medicament for treating and/or preventing tauopathy, comprising a Nav activator as an active ingredient.
本发明提供了一种通过激活电压门控钠通道(Nav)治疗和/或预防tau病的药物。本发明涉及一种治疗和/或预防tau病的药物,其包括Nav激活剂作为活性成分。